Beth Weinberg
General Counsel chez CARA THERAPEUTICS, INC.
Profil
Beth Weinberg currently works at CARA Therapeutics, Inc., as Senior Vice President-Regulatory Affairs.
Ms. Weinberg also formerly worked at Angion Biomedica Corp., as Vice President & Head-Regulatory and Metavant Sciences, Inc., as VP, Head-Regulatory Affairs & Quality.
Ms. Weinberg received her undergraduate degree from Butler University and undergraduate degree from Bradley University.
Postes actifs de Beth Weinberg
| Sociétés | Poste | Début |
|---|---|---|
| CARA THERAPEUTICS, INC. | General Counsel | - |
Anciens postes connus de Beth Weinberg
| Sociétés | Poste | Fin |
|---|---|---|
| ANGN BIOM | General Counsel | - |
| Metavant Sciences, Inc. | General Counsel | - |
Formation de Beth Weinberg
| Butler University | Undergraduate Degree |
| Bradley University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CARA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
| Metavant Sciences, Inc. |
